InsiderClue
← All stocks

ProQR Therapeutics N.V.

PRQR Net buying
CIK 0001612940 #3479 in the set updated 17 Sep 2026
Bought (120 mo)
$1.34M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$1.34M
+$1.34M against sales at will

By person

2 insiders · 5 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
de Boer Daniel Anton
Chief Executive Officer
$853.46K (3)
—
+$853.46K
500,000
0.4746%
$884.90K
—
Filius Bart
Director
$488.93K (2)
—
+$488.93K
300,000
0.2847%
$530.94K
—

Individual transactions

5
Insider
Date
Role
Action
Shares
Price
Amount
de Boer Daniel Anton
31 Jul 2026
Chief Executive Officer
Buy
200,000
$1.77
$353.96K
Filius Bart
17 Jul 2026
Director
Buy
150,000
$1.72
$257.93K
de Boer Daniel Anton
9 Jul 2026
Chief Executive Officer
Buy
150,000
$1.74
$261.00K
de Boer Daniel Anton
7 Jul 2026
Chief Executive Officer
Buy
150,000
$1.59
$238.50K
Filius Bart
26 Jun 2026
Director
Buy
150,000
$1.54
$231.00K
Show all 5 transactions →

What was left out

Form 4 filings counted 6
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 3 Jun 2026